When was Sherlock founded?

Sherlock was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is Sherlock located?

Sherlock is headquartered in Watertown, United States.

How many employees does Sherlock have?

As of Mar 01, 2026, the latest employee count at Sherlock is 50 - 199.

Is Sherlock a funded company?

Sherlock is a funded company, having raised a total of $111M across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 23, 2019.

When was the latest funding round of Sherlock?

Sherlock's latest funding was a $***** Grant (prize money) round on Jun 09, 2025, with participation from 1 investor.

Where does Sherlock rank among its competitors?

Sherlock ranks 27th amongst 297 active competitors, of which 118 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Sherlock?

Sherlock's top competitors include Ginkgo Bioworks, Syngenta and GRAIL. Among them, Antheia secured the most recent funding round in January, 2026.

Sherlock - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a diagnostic platform for DNA and RNA detection. The company has developed proprietary CRISPR-based SHERLOCK and synthetic biology-based INSPECTR technologies to create diagnostic tools for the detection of infectious disease, early detection of cancer, treatment monitoring, and precision medicine.

Website: sherlock.bio
Social
Email ID: *****@sherlock.bio
Phone Number: +1 **********

Key Metrics

Founded Year

2019

Location

Watertown, United States

Stage

Acquired

Total Funding

$111M in 9 rounds

Latest Funding Round

Grant (prize money), Jun 09, 2025, $*****

Investors

Open Philanthropy & 13 more

Ranked

27^th among 297 active competitors

Employee Count

50 - 199 as on Mar 01, 2026

Investment & Acquisitions

Sense Biodetection

Similar Companies

Ginkgo Bioworks & 385 more

Exit Details

Acquired by OraSure (Dec 19, 2024)

View Sherlock's full profile

Sherlock is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sherlock Biosciences, Inc CIN: 82-4558450 , United States, Active	Dec 31, 2017	-	33 (As on Dec 31, 2020)	-

Sherlock got acquired by OraSure on Dec 19, 2024.

Click here to take a look at Sherlock's acquisition in detail

Sherlock has raised a total funding of $111M over 9 rounds. Its first funding round was on Apr 23, 2019. Its latest funding round was a Grant (prize money) round on Jun 09, 2025 for $*****. 1 investor participated in its latest round. Sherlock has 14 institutional investors.

Here is the list of recent funding rounds of Sherlock:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 09, 2025	6976808	Grant (prize money)	4801834	4560902	4464598	4739681
Aug 08, 2024	8260659	Grant (prize money)	7033585	8190995	8969823	United States Department of Agriculture
Jul 01, 2023	1039478	Grant (prize money)	2929591	5424384	4827075	United States Department of Agriculture

Access funding benchmarks and valuations. Sign up today!

View details of Sherlock's funding rounds and investors

The founders of Sherlock are Jonathan Gootenberg, David Walt and Omar Abudayyeh.

Here are the details of Sherlock's key team members:

Jonathan Gootenberg: Co-Founder of Sherlock.
David Walt: Co-Founder of Sherlock.
Contact Info: 1 email address
Omar Abudayyeh: Co-Founder of Sherlock.

View details of Sherlock's Founder profiles and Board Members

Sherlock's employee count trend

Sherlock has 50 - 199 employees as of Mar 26. Here is Sherlock's employee count trend over the years:

Uncover Sherlock's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sherlock include Ginkgo Bioworks, Syngenta and GRAIL. Here is the list of Top 10 competitors of Sherlock, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
3rd	GRAIL 2016, Menlo Park (United States), Public	Developer of a screening platform for circulating tumor DNA to detect cancer	$2B	Arch Venture Partners, Bezos Expeditions ... & 51 others	72/100
4th	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, RA Capital Management & 30 others	71/100
5th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Fidelity Investments, Foresite Capital & 39 others	70/100
6th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	EDBI, Casdin Capital & 12 others	68/100
7th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
8th	Amyris 2003, Emeryville (United States), Public	Developer of renewable products for industrial solutions	$487M	Temasek, Grupo Cornelio Brennand & 24 others	68/100
9th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
10th	UDX 2012, Seville (Spain), Series C	Developer of non-invasive blood-based diagnostics for cancer	$105M	Quest Diagnostics, Olympus & 6 others	67/100
27th	Sherlock 2019, Watertown (United States), Acquired	Provider of a diagnostic platform for DNA and RNA detection	$111M	Novalis LifeSciences, Northpond Ventures ... & 12 others	55/100